Latent inhibition as a model of schizophrenia: From learning to psychopathology;La inhibición latente como modelo de la esquizofrenia: Del aprendizaje a la psicopatología

International Journal of Psychology and Psychological Therapy

Volumn 3, Issue 2, 2003, Pages 251-266

  Álvarez, Roberto ^a   de la Casa, Luis G ^b   Sánchez, Pilar ^c  

^a UNIVERSITY OF ALMERÍA   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

Author keywords

Antipsychotic drugs; Conditioning; Latent inhibition; Latent inhibition model; Schizophrenia; Schizotypy; Selective attention

Indexed keywords

EID: 70350704992     PISSN: 15777057     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Baruch, I., Hemsley, D.R. & Gray, J.A. (1988). Differential performance of acute and chronic schizophrenics in a latent inhibition task. Journal of Nervous and Mental Disease, 176, 598- 606.
2. Braff, D.L. (1993). Information processing and attention dysfunctions in schizophrenia. Schizophrenia Bulletin, 125, 171-186.
3. Braustein-Bercovitz, H. (2000). Is the attentional dysfunction in schyzotypy related to anxiety. Schizophrenia Research, 46, 255-267.
4. Braunstein-Bercovitz H. & Lubow, R.E. (1998a). Latent inhibition as a function of modulation of attention to the pre-exposed irrelevant stimulus. Learning and Motivation, 29, 261-279.
5. Braunstein-Bercovitz, H. & Lubow, R.E. (1998b). Are high schyzotypals normal participants distractible or limited in attentional resources? A study of latent inhibition as function of masking load and schyzotype level. Journal of Abnormal Psychology, 107, 659-670.
6. Braunstein-Bercovitz, H., Rammsayer, T., Gibbons, H. & Lubow, R.E. (2002). Latent inhibition deficits in high-schyzotypal normals: symptom-specific or anxiety-related?. Schizophrenia Research, 53,109-121.
7. Cassaday, H.J. (1997). Latent inhibition: relevance to the neural substrates of schizophrenia and schizotypy? In G. Claridge. Schizotypy. Implications for illness and health. Oxford: Oxford University Press (pp. 124-144).
8. Claridge, G.S. (1987). The schizophrenias as nervous types. British Journal of Psychiatry, 151, 735- 743.
9. Claridge, G. (1999). Esquizotipia: Teoría y medición. Revista Argentina de Clínica Psicológica, 8, 35- 51.
10. Daza, M.T., López, G. & Álvarez, R. (2002). Procedimientos experimentales en el estudio de la inhibición latente en humanos. International Journal of Psychology and Psycological Therapy, 2, 75-99.
11. De la Casa, L.G. (2002). La inhibición latente como un procedimiento de análisis del proceso atencional ante estímulos irrelevantes. Revista de Psicología General y Aplicada, 55, 263-283.
12. De la Casa, L.G., Ruíz, G. & Lubow, R.E. (1993a). Amphetamine-produced attenuation of latent inhibition is modulated by stimulus preexposure duration: Implications for schizophrenia. Biological Psychiatry, 33, 707-711.
13. De la Casa, L. G., Ruíz, G. & Lubow, R. E. (1993b). Latent inhibition and recall/recognition of irrelevant stimuli as a function of preexposure duration in high and low psychotic-prone normal subjects. British Journal of Psychology, 84, 119-132.
14. De la Casa, L.G., Ruíz, G. & Sánchez, N. (2003). La modulación del aprendizaje tras la preexposición no reforzada de estímulos irrelevantes. In J. Vila, J. Nieto y J.M. Rosas (eds.). Investigación contemporánea en aprendizaje asociativo. Jaén: Del Lunar (pp. 67-82).
15. Fernández, F. & De la Casa, L.G. (1989). Una revisión teórica de los intentos explicativos de la inhibi-ción latente. Revista de Psicología General y Aplicada, 42, 425-439.
16. Ginton, A., Urca, G. & Lubow, R. E. (1975). The effect of preexposure to a nonattended stimulus on subsequent learning: latent inhibition in adults. Bulletin of the Psychonomic Society, 5, 5-8.
17. Gray, J.A. (1998). Integrating schizophrenia. Schizophrenia Bulletin, 24, 249-266.
18. Gray, J.A., Feldon, J., Rawlins, J.N.P., Hemsley, D.R. & Smith, A.D. (1991). The neuropsychology of schizophrenia. Behaviour and Brain Sciences, 14, 1-84.
19. Gray, N.S., Hemsley, D.R. & Gray, J.A.(1992). Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurology Psychiatry and Brain Research, 1, 83-89.
20. Gray, N.S., Pickering, A.D., Hemsley, D.R., Dawling, S. & Gray, J.A. (1992). Abolition of latent inhibition by a single 5 mg. dose of d-amphetamine in man. Psychopharmacology, 107, 425- 430.
21. Hemsley, D.R. (1987). An experimental psychological model for schizophrenia. In H. Häfner, W.F. Fattaz and W. Janzavik (eds.). Search for the Causes of Schizophrenia. Stuttgart, Germany: Springer-Verlag. (pp. 179-188).
22. Lipska, B.K. and Weinberger, D.R. (2000). To model a psychiatric disorder in animals: Schizophrenia as a reality test. Neuropsychopharmacology, 23, 223-239.
23. Lubow, R.E. (1989). Latent Inhibition and Conditioned Attention Theory. Cambridge: Cambridge University Press.
24. Lubow. R.E. and Gewirtz, J.C. (1995). Latent inhibition in humans: Data, Theory, and Implications for Schizophrenia. Psychological Bulletin, 117, 87-103.
25. Mason, O., Claridge, G. & Jackson, M. (1995). New scales for the assessment of schizotypy. Personality and Individual Differences, 18, 7-13.
26. Myslobodsky, M. & Weiner, I. (2000). Contemporary issues in modeling psychopathology. Massachusetts: Kluwer.
27. Overmier, J.B. (2001). Del laboratorio a la clínica: Una parábola moderna. Revista Mexicana de Psicología, 16, 287-300.
28. Raine, A. (1991). The SPQ: A scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophrenia Bulletin, 17, 555-564.
29. Rascle, C., Mazas, O., Vaiva, G., Tournant, M., Raybois, O., Goudermand, M. & Thomas P. (2001). Clinical features of latent inhibition in schizophrenia. Schizophrenia Research, 51, 149-161.
30. Rascle, C., Soller, J., Goudemand, M. & Thomas, P. (2003). Latent inhibition in first episode of schizophrenia. 9th International Congress on Schizophrenia Research. Volume 60, issue 1, Supplement 1. Colorado Springs, Colorado. March 29th-April 2nd.
31. Sánchez, P., Sánchez-Elvira, M.A., Hernández, F., Amor, P. & Lasa, A. (in preparation). Modulación de la inhibición latente en función del componente negativo versus positivo de la esquizotipia.
32. Shadach, E., Gaisler, I, Schiller, D. & Weiner, I. (2000). The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin. Neuropsychopharmachology, 23, 151-161.
33. Simosky, J.K., Stevens, K.E., Adler, L.E. & Freedman, R. (2003). Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism. Psychopharmacology, 165, 386-396.
34. Spielberger, C.D., Gorsuch, R.L. & Lushene, R.E. (1970). Manual for the State-Trait Anxiety Inventory (Self-Evaluation Questionnaire). Palo Alto, CA: Consulting Psychologists Press.
35. Weiner, I. (1990). Neural substrates of latent inhibition: The switching model. Psychological Bulletin, 108, 443-461.
36. Weiner, I. (2003). The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology. Published online: 25 February 2003.
37. Williams, L. & Beech, A. (1997). Investigations of cognitive inhibitory processes in schizotypy and schizophrenia. In G. Claridge (ed.). Schyzotypy. Implications for illness and health. Oxford: Oxford University Press. (pp. 63-79).